Investing Profile

Hakan Goker

InvestorVC
Managing Director at M Ventures (Merck)
m-ventures.com/enAmsterdam, Netherlands
Photo of Hakan Goker, Managing Director at M Ventures (Merck)
Your Intro Paths to Hakan Goker

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Hakan Goker on

cb
Current Investing Position
M Ventures (Merck) Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
19
Current Fund Size
€600M

Hakan Goker is on these Sector & Stage Rankings

Hakan Goker's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Asceneuron
Series CJul 2024$100M
Series ASep 2015$31M
$130M
Co-investors: Henrijette Richter (Soffinova Partners), Philip Scheltens (EQT Life Sciences)
iOnctura
Series BJun 2024$86M
Series AJul 2020$6M
Series AJan 2020$17M
SeedJun 2017
$110M
Co-investors: Keno Gutierrez (BGV (BioGeneration Ventures)), Fiona MacLaughlin (Johnson & Johnson Innovation), Roel Bulthuis (INKEF Capital)
Nouscom
Series CNov 2023$73M
$140M
Co-investors: Scott Rocklage (5am Ventures), Sofia Ioannidou (Andera Partners), Guido Magni (Versant Ventures), Joachim Rothe (EQT Life Sciences), Genghis Lloyd-Harris (Abingworth)
Storm Therapeutics
Series BDec 2022$30M
Series AMay 2019$18M
Series AJun 2016$16M
$69M
Co-investors: Bruno Montanari (Seroba Life Sciences), Sakae Asanuma (Taiho Ventures)
Artios Pharma
Series CJul 2021$150M
Series ASep 2016$33M
$270M
Co-investors: René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments)
Forendo Pharma
Series UnknownJul 2019$6M
Series UnknownSep 2018$5M
Series AOct 2014$15M
$26M
Co-investors: Anja Konig (Novartis Venture Fund)
Ribometrix
Series ANov 2018$30M
$38M
Co-investors: John Gustofson (AbbVie Ventures), Mike Dial (Hatteras Venture Partners)
Macrophage Pharma
Series AJan 2017$11M
$11M